FY2025 · period end Dec '25 · from the 10-K filed Feb 6, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $5.83B | $4.92B | $4.50B | $4.13B | $3.83B |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | — | — | — | — | — |
| EPS (Diluted) | $0.54 | $0.19 | negative: -$0.10 | negative: -$0.12 | $0.13 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $27.59B | $26.19B | $24.73B | $24.16B | $24.72B |
| Total Liabilities | $14.63B | $15.05B | $14.88B | $13.67B | $13.49B |
| Stockholders' Equity | $12.59B | $10.83B | $9.54B | $10.22B | $10.95B |
| Cash & Equivalents | $0.74B | $0.90B | $0.51B | $0.12B | $0.15B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.65B | $1.33B | $1.12B | $1.12B | $1.03B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | negative: -0.3% | negative: -0.3% | negative: -0.3% | negative: -0.3% | — |
| Net Margin | negative: -0.2% | negative: -0.2% | negative: -0.2% | negative: -0.2% | — |
| Return on Equity | negative: -7.9% | negative: -7.6% | negative: -9.7% | negative: -8.1% | — |
| Return on Assets | negative: -3.5% | negative: -3.0% | negative: -3.9% | negative: -3.5% | — |
| Debt / Equity | — | — | — | 0.04× | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0000740260-26-000024 | Jun 30, 2026 | Jul 30, 2026 | Jul 30, 2026 20:33 UTC | EDGAR |
| 8-K | 0000740260-26-000022 | Jul 29, 2026 | Jul 29, 2026 | Jul 29, 2026 20:39 UTC | EDGAR |
| 8-K | 0001104659-26-074016 | Jun 15, 2026 | Jun 15, 2026 | Jun 15, 2026 20:02 UTC | EDGAR |
| 8-K | 0001104659-26-062795 | May 12, 2026 | May 15, 2026 | May 15, 2026 21:15 UTC | EDGAR |
| 10-Q | 0000740260-26-000018 | Mar 31, 2026 | Apr 28, 2026 | Apr 28, 2026 20:08 UTC | EDGAR |
| 8-K | 0000740260-26-000016 | Apr 27, 2026 | Apr 27, 2026 | Apr 27, 2026 20:33 UTC | EDGAR |
| 8-K | 0001104659-26-018206 | Feb 16, 2026 | Feb 20, 2026 | Feb 20, 2026 22:00 UTC | EDGAR |
| 8-K | 0001104659-26-011786 | Feb 9, 2026 | Feb 9, 2026 | Feb 9, 2026 13:32 UTC | EDGAR |
Direct links to SEC EDGAR. VTR has additional filings available on the SEC site.
6 numbers Ventas, Inc. later changed — same XBRL tag, both filings linked.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2013
Major restatementwas$479M
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2014
Major restatementwas$448.5M
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q3 2014
Major restatementwas$104.5M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q1 2015
Major restatementwas$107.5M
Revised down in a 10-Q.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2015
Major restatementwas$133M
Revised down in a 10-Q.
Revenues·Q1 2014
Major restatementwas$741.5M
Revised down in a 10-K. Any P/S built on the original was 11.5% too low.
VTR is not the only one.
See every restatement we've found across the market — or get an alert the next time VTR revises a number.
Restatements are detected by comparing every vintage of a fact across all of Ventas, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows VTR's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Ventas, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on VTR yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on VTR and publish the result to your public profile.
Ask about Ventas, Inc.
Continue in Workspace — cited answers on VTR, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs